Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Q3 Operating Loss Widens To SEK 11.5 Mln

Nov 15 (Reuters) - Kancera AB  KANC.ST :
    * OPERATING LOSS FOR Q3 AMOUNTED TO SEK -11,5 MILLION (SEK
-10,5
MILLION)

Source text:  ID:nMFN69dWwp 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

Recent news on Novakand Pharma AB

See all news